Chemiplasmonics for high-throughput biosensors
Received 6 September 2018
Accepted for publication 18 October 2018
Published 27 November 2018 Volume 2018:13 Pages 8051—8062
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Thomas Webster
Achyut J Raghavendra,1,* Jingyi Zhu,1,* Wren Gregory,1 Fengjiao Case,1 Pradyumna Mulpur,2 Shahzad Khan,3 Anurag Srivastava,3 Ramakrishna Podila1
1Laboratory of Nano-biophysics, Clemson University, Clemson, SC 29634, USA; 2Clemson Nanomaterials Institute, Clemson University, Anderson, SC 29625, USA; 3ABV-Indian Institute of Information Technology and Management, Gwalior, MP, India
*These authors contributed equally to this work
Background: The sensitivity of ELISA for biomarker detection can be significantly increased by integrating fluorescence with plasmonics. In surface-plasmon-coupled emission, the fluorophore emission is generally enhanced through the so-called physical mechanism due to an increase in the local electric field. Despite its fairly high enhancement factors, the use of surface-plasmon-coupled emission for high-throughput and point-of-care applications is still hampered due to the need for expensive focusing optics and spectrometers.
Methods: Here, we describe a new chemiplasmonic-sensing paradigm for enhanced emission through the molecular interactions between aromatic dyes and C60 films on Ag substrates.
Results: A 20-fold enhancement in the emission from rhodamine B-labeled biomolecules can be readily elicited without quenching its red color emission. As a proof of concept, we demonstrate two model bioassays using: 1) the RhB–streptavidin and biotin complexes in which the dye was excited using an inexpensive laser pointer and the ensuing enhanced emission was recorded by a smartphone camera without the need for focusing optics and 2) high-throughput 96-well plate assay for a model antigen (rabbit immunoglobulin) that showed detection sensitivity as low as 6.6 pM.
Conclusion: Our results show clear evidence that chemiplasmonic sensors can be extended to detect biomarkers in a point-of-care setting through a smartphone in simple normal incidence geometry without the need for focusing optics. Furthermore, chemiplasmonic sensors also facilitate high-throughput screening of biomarkers in the conventional 96-well plate format with 10–20 times higher sensitivity.
Keywords: biosensor, surface plasmons, nanosilver, fluorescence, fullerenes
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]